Heart Risk When You Look Fit
Someone who trains three or four times a week, whose weight has not moved much in a decade, whose annual panel came back with a note saying everything looks good — and whose actual cardiovascular risk was never measured.
That is not a failure of the panel. It is a limitation of what a standard lipid panel is designed to do, and there are two markers that fill most of the gap.
The pattern is common enough to be a type. Someone who trains three or four times a week, whose weight has not moved much in a decade, whose annual panel came back with a note saying everything looks good — and whose actual cardiovascular risk was never measured.
That is not a failure of the panel. It is a limitation of what a standard lipid panel is designed to do, and there are two markers that fill most of the gap.
What a standard panel actually measures
A routine lipid panel gives you total cholesterol, HDL, triglycerides, and an LDL-C figure that is usually calculated rather than directly measured. LDL-C is an estimate of how much cholesterol is being carried inside your LDL particles.
The distinction that matters: cholesterol is cargo, and particles are what interact with the artery wall. Two people can carry the same amount of cholesterol in very different numbers of particles. The one with more particles is at higher risk, and the LDL-C figure does not distinguish between them.
That mismatch is most pronounced in exactly the metabolic profile this population tends to have — higher triglycerides, lower HDL, a normal-looking LDL-C.
ApoB: counting the particles
Every atherogenic particle carries exactly one apolipoprotein B molecule. Measuring ApoB therefore counts particles directly rather than estimating their contents.
The 2026 ACC/AHA dyslipidemia guideline says ApoB may be used to assess residual cardiovascular risk and guide treatment in people with cardiovascular-kidney-metabolic syndrome, type 2 diabetes, high triglycerides or known cardiovascular disease who have already reached their LDL-C and non-HDL-C goals. In those groups it may be a more accurate risk marker than LDL-C. That is a permission, not a blanket recommendation, and it is scoped to those groups rather than to everyone at target.
The practical translation: if your LDL-C is at target and you have any of those features, the target may not mean what it appears to mean, and ApoB is how you find out.
Lp(a): the one you need once
Lipoprotein(a) is the more interesting of the two, because it is the one almost nobody has had drawn.
It is largely genetically determined and stays broadly stable across a lifetime. Diet does not move it much. Exercise does not move it much. That stability is precisely why the 2026 ACC/AHA dyslipidemia guideline says it should be measured at least once in adulthood — and why repeat testing is generally unnecessary.
An Lp(a) of 125 nmol/L or higher — about 50 mg/dL — is associated with roughly a 1.4-fold increase in long-term risk of heart attack or stroke. At around 250 nmol/L the association is at least a doubling. If you have a family history of early heart disease that never got explained, this is frequently the explanation. It is also the reason a result matters for your siblings and your children, not only for you.
Knowing an elevated Lp(a) does not, by itself, come with a drug that lowers it in routine practice today. What it does is change how aggressively everything else you can modify gets managed, and it changes the conversation with your family.
Where a demanding career fits into this
Three of the pressures on this audience move cardiometabolic markers directly, and they compound.
Hours. Joint estimates from the World Health Organization and the International Labour Organization attributed 398,000 stroke deaths and 347,000 heart disease deaths in 2016 to working 55 hours a week or more — an estimated 35% higher risk of stroke, and a 17% higher risk of dying from ischemic heart disease, against a 35-to-40-hour week. Most of those deaths were in people aged 60 to 79 who had worked those hours between 45 and 74.
Travel. In corporate travelers, the heaviest travelers had higher diastolic blood pressure, lower HDL and markedly higher odds of obesity than people traveling one to six nights a month — as did people who never travel for work at all, which is worth knowing before reading the finding as a straight line. More on travel and your markers.
Sleep. Untreated obstructive sleep apnea is one of the more common contributors to blood pressure that will not come down on medication — and it is the single most commonly missed issue we see in this group. We screen for it with a validated questionnaire and refer for a sleep study; we do not diagnose it.
None of this is exotic. It is that the ordinary structure of a senior job pushes several cardiometabolic markers in the same direction at once, and an annual snapshot inside a reference range is not built to detect that.
What we do with it
Our panel covers lipids alongside metabolic, liver, kidney, thyroid, inflammatory, nutrient and hormonal markers, read against your history rather than against population ranges alone. Where an advanced lipid marker is warranted, that is a conversation with a clinician rather than a box on a menu.
What we do not do is imaging. If a coronary calcium score or an echocardiogram is the right next step, that is a referral — and for some people it is the right next step. We will say so. We also do not diagnose or treat cardiovascular disease; we measure, interpret and refer.
And we will not tell you that optimizing a marker extends your lifespan. That is not established, whatever the category claims.
Where this fits in your plan
Start with a baseline panel read against your history, and a conversation about what your family history and current markers justify adding.
Frequently asked questions
Possibly. A normal LDL-C with high triglycerides and low HDL is the profile where LDL-C is least reliable as a risk estimate, and it is a common one in this population.
Current guidance points toward measuring it at least once in adulthood. Because it is genetically determined and stable, once is generally enough — which makes it unusual among lab tests, and a reasonable thing to have on the record.
It changes how aggressively the risk factors you can modify get managed, and it is worth telling your first-degree relatives, since it is inherited. Discuss the specifics with a clinician who knows your full history.
In specific populations — metabolic syndrome, type 2 diabetes, high triglycerides, or established cardiovascular disease already at LDL-C target — it gives a more accurate risk read. It is a refinement rather than a wholesale replacement.
No. We do no imaging of any kind. If one is indicated, we refer.
It helps substantially, and it does not neutralize Lp(a), which is genetic. Fitness is a reason to have good markers, not a reason to assume you do.
References
Government and professional-society sources consulted for this page.
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia — Journal of the American College of Cardiology (2026)
- ACC/AHA issue updated guideline for managing lipids, cholesterol — American Heart Association Newsroom (2026)
- Long working hours increasing deaths from heart disease and stroke — World Health Organization / International Labour Organization (2021)
- Business Travel and Self-rated Health, Obesity, and Cardiovascular Disease Risk Factors — Journal of Occupational and Environmental Medicine (2011)
- Blood Cholesterol — National Heart, Lung, and Blood Institute
- Sleep Apnea — National Heart, Lung, and Blood Institute
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.